drugset / Trial / NCT05155722
Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
A phase I dose escalation and cohort expansion study to evaluate the safety, tolerance and pharmacokinetic of BAT1308 injection in patients with advanced solid tumors
Timeline
- Start
- 2020-09-17
- Primary completion
- 2024-07-09
- Completion
- 2024-07-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BAT1308 | Monoclonal antibody | 100 mg | — |
| Subject | BAT1308 | Monoclonal antibody | 300 mg | — |
| Subject | BAT1308 | Monoclonal antibody | 600 mg | — |